Compare VSTD & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSTD | TOVX |
|---|---|---|
| Founded | 2016 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 7.3M |
| IPO Year | 2022 | 2006 |
| Metric | VSTD | TOVX |
|---|---|---|
| Price | $0.23 | $0.19 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 659.1K | ★ 3.0M |
| Earning Date | 03-27-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,902,861.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.39 | N/A |
| 52 Week Low | $0.20 | $0.17 |
| 52 Week High | $5.63 | $2.03 |
| Indicator | VSTD | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.40 |
| Support Level | N/A | $0.17 |
| Resistance Level | N/A | $0.23 |
| Average True Range (ATR) | 0.00 | 0.02 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 32.34 |
Vestand Inc is a California-based fast-growing restaurant operator expanding into the real estate investment and development sector. It is a PropTech company engaged in AI-driven real estate investment and security token offerings (STOs). It provides services such as Property Acquisition, Property Development, Financial Management, and Property Management.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.